Literature DB >> 21091777

Obstruction of the lung capillaries by blood platelet aggregates and leucocytes in sudden infant death syndrome.

Tor-Arne Hanssen1, Leif Jørgensen.   

Abstract

Altogether 34 cases of sudden infant death were studied postmortem with particular emphasis on the pathological changes in the lungs. Light microscopy, including application of immunohistochemical methods, and transmission electron microscopy were used for the identification of blood platelets and white blood cell types in alveolar capillaries. The main findings were platelet aggregates and a varying number of neutrophil polymorphonuclear granulocytes in the lung capillaries, mixed with a smaller number of lymphocytes. The findings may be interpreted as an early sign of inflammation with capillary thrombosis, resulting in ischaemia, i.e. arrest of flow. In 21% of the cases, inflammatory cells had also expanded focally into alveolar spaces, creating the picture of localized areas of bronchopneumonia. An infant dying suddenly of a traumatic head injury served as a control. Neither platelets nor leucocytes were observed in the alveolar capillaries of this infant. In conclusion, in lungs from cases of sudden infant death syndrome, the alveolar capillaries are obstructed by platelet aggregates and leucocytes, interpreted as signs of an initial stage of lung inflammation with ischaemia.
© 2010 The Authors. Journal Compilation © 2010 APMIS.

Entities:  

Mesh:

Year:  2010        PMID: 21091777     DOI: 10.1111/j.1600-0463.2010.02651.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  2 in total

1.  Age-related differences in cigarette smoke extract-induced H2O2 production by lung endothelial cells.

Authors:  Charles A Downs; David W Montgomery; Carrie J Merkle
Journal:  Microvasc Res       Date:  2011-10-06       Impact factor: 3.514

2.  Platelets in pulmonary vascular physiology and pathology.

Authors:  Michael H Kroll; Vahid Afshar-Kharghan
Journal:  Pulm Circ       Date:  2012-07       Impact factor: 3.017

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.